Reaction Details |
| Report a problem with these data |
Target | 5-hydroxytryptamine receptor 2B |
---|
Ligand | BDBM50302141 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_598880 (CHEMBL1047256) |
---|
EC50 | >10000±n/a nM |
---|
Citation | Allerton, CM; Andrews, MD; Blagg, J; Ellis, D; Evrard, E; Green, MP; Liu, KK; McMurray, G; Ralph, M; Sanderson, V; Ward, R; Watson, L Design and synthesis of pyridazinone-based 5-HT(2C) agonists. Bioorg Med Chem Lett19:5791-5 (2009) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
5-hydroxytryptamine receptor 2B |
---|
Name: | 5-hydroxytryptamine receptor 2B |
Synonyms: | 5-HT-2B | 5-HT2B | 5-hydroxytryptamine (serotonin) receptor 2B [Homo sapiens] | 5-hydroxytryptamine receptor 2B (5-HT2B) | 5-hydroxytryptamine receptor 2C (5HT2C) | 5HT2B_HUMAN | HTR2B | Serotonin (5-HT3) receptor | Serotonin 2b (5-HT2b) receptor | Serotonin Receptor 2B |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 54312.47 |
Organism: | Homo sapiens (Human) |
Description: | Receptor binding assays were performed using human clone stably expressed in CHO cells. |
Residue: | 481 |
Sequence: | MALSYRVSELQSTIPEHILQSTFVHVISSNWSGLQTESIPEEMKQIVEEQGNKLHWAALL
ILMVIIPTIGGNTLVILAVSLEKKLQYATNYFLMSLAVADLLVGLFVMPIALLTIMFEAM
WPLPLVLCPAWLFLDVLFSTASIMHLCAISVDRYIAIKKPIQANQYNSRATAFIKITVVW
LISIGIAIPVPIKGIETDVDNPNNITCVLTKERFGDFMLFGSLAAFFTPLAIMIVTYFLT
IHALQKKAYLVKNKPPQRLTWLTVSTVFQRDETPCSSPEKVAMLDGSRKDKALPNSGDET
LMRRTSTIGKKSVQTISNEQRASKVLGIVFFLFLLMWCPFFITNITLVLCDSCNQTTLQM
LLEIFVWIGYVSSGVNPLVYTLFNKTFRDAFGRYITCNYRATKSVKTLRKRSSKIYFRNP
MAENSKFFKKHGIRNGINPAMYQSPMRLRSSTIQSSSIILLDTLLLTENEGDKTEEQVSY
V
|
|
|
BDBM50302141 |
---|
n/a |
---|
Name | BDBM50302141 |
Synonyms: | 2-(2-(2-chlorophenoxy)ethyl)-6-(piperazin-1-yl)pyridazin-3(2H)-one | CHEMBL570937 |
Type | Small organic molecule |
Emp. Form. | C16H19ClN4O2 |
Mol. Mass. | 334.801 |
SMILES | Clc1ccccc1OCCn1nc(ccc1=O)N1CCNCC1 |
Structure |
|